{"id":"https://openalex.org/W2805217833","doi":"https://doi.org/10.1080/14017431.2018.1480798","title":"Dabigatran affects thrombin-dependent platelet aggregation after a week-long therapy","display_name":"Dabigatran affects thrombin-dependent platelet aggregation after a week-long therapy","publication_year":2018,"publication_date":"2018-05-29","ids":{"openalex":"https://openalex.org/W2805217833","doi":"https://doi.org/10.1080/14017431.2018.1480798","mag":"2805217833","pmid":"https://pubmed.ncbi.nlm.nih.gov/29842807"},"language":"en","primary_location":{"id":"doi:10.1080/14017431.2018.1480798","doi":"https://doi.org/10.1080/14017431.2018.1480798","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14017431.2018.1480798","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14017431.2018.1480798?needAccess=true&role=button","source":{"id":"https://openalex.org/S1492939","display_name":"Scandinavian Cardiovascular Journal","issn_l":"1401-7431","issn":["1401-7431","1651-2006"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scandinavian Cardiovascular Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/14017431.2018.1480798?needAccess=true&role=button","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090258329","display_name":"Juraj Sokol","orcid":"https://orcid.org/0000-0003-2786-0505","observed_orcids":["https://orcid.org/0000-0003-2786-0505"]},"institutions":[{"id":"https://openalex.org/I74788687","display_name":"Comenius University Bratislava","ror":"https://ror.org/0587ef340","country_code":"SK","type":"education","lineage":["https://openalex.org/I74788687"]}],"countries":["SK"],"is_corresponding":false,"raw_author_name":"Juraj Sokol","raw_affiliation_strings":["Department of Haematology and Transfusion Medicine, National Centre of Haemostasis and Thrombosis, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Kollarova 2, 036 59 Martin, Slovakia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology and Transfusion Medicine, National Centre of Haemostasis and Thrombosis, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Kollarova 2, 036 59 Martin, Slovakia;","institution_ids":["https://openalex.org/I74788687"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013258073","display_name":"Franti\u0161ek Neh\u00e1j","orcid":"https://orcid.org/0000-0003-3070-5776","observed_orcids":["https://orcid.org/0000-0003-3070-5776"]},"institutions":[{"id":"https://openalex.org/I74788687","display_name":"Comenius University Bratislava","ror":"https://ror.org/0587ef340","country_code":"SK","type":"education","lineage":["https://openalex.org/I74788687"]}],"countries":["SK"],"is_corresponding":true,"raw_author_name":"Frantisek Nehaj","raw_affiliation_strings":["First Department of Internal Medicine, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Kollarova 2, 036 59 Martin, Slovakia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"First Department of Internal Medicine, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Kollarova 2, 036 59 Martin, Slovakia","institution_ids":["https://openalex.org/I74788687"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110386206","display_name":"Jela Ivankov\u00e1","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I74788687","display_name":"Comenius University Bratislava","ror":"https://ror.org/0587ef340","country_code":"SK","type":"education","lineage":["https://openalex.org/I74788687"]}],"countries":["SK"],"is_corresponding":false,"raw_author_name":"Jela Ivankova","raw_affiliation_strings":["Department of Haematology and Transfusion Medicine, National Centre of Haemostasis and Thrombosis, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Kollarova 2, 036 59 Martin, Slovakia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology and Transfusion Medicine, National Centre of Haemostasis and Thrombosis, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Kollarova 2, 036 59 Martin, Slovakia;","institution_ids":["https://openalex.org/I74788687"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110624325","display_name":"Michal Mok\u00e1\u0148","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I74788687","display_name":"Comenius University Bratislava","ror":"https://ror.org/0587ef340","country_code":"SK","type":"education","lineage":["https://openalex.org/I74788687"]}],"countries":["SK"],"is_corresponding":false,"raw_author_name":"Michal Mokan","raw_affiliation_strings":["First Department of Internal Medicine, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Kollarova 2, 036 59 Martin, Slovakia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"First Department of Internal Medicine, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Kollarova 2, 036 59 Martin, Slovakia","institution_ids":["https://openalex.org/I74788687"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021414260","display_name":"Marian Mok\u00e1\u0148","orcid":"https://orcid.org/0000-0002-9674-1799","observed_orcids":["https://orcid.org/0000-0002-9674-1799"]},"institutions":[{"id":"https://openalex.org/I74788687","display_name":"Comenius University Bratislava","ror":"https://ror.org/0587ef340","country_code":"SK","type":"education","lineage":["https://openalex.org/I74788687"]}],"countries":["SK"],"is_corresponding":false,"raw_author_name":"Marian Mokan","raw_affiliation_strings":["First Department of Internal Medicine, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Kollarova 2, 036 59 Martin, Slovakia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"First Department of Internal Medicine, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Kollarova 2, 036 59 Martin, Slovakia","institution_ids":["https://openalex.org/I74788687"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008216380","display_name":"J\u00e1n Sta\u0161ko","orcid":"https://orcid.org/0000-0003-3305-0269","observed_orcids":["https://orcid.org/0000-0003-3305-0269"]},"institutions":[{"id":"https://openalex.org/I74788687","display_name":"Comenius University Bratislava","ror":"https://ror.org/0587ef340","country_code":"SK","type":"education","lineage":["https://openalex.org/I74788687"]}],"countries":["SK"],"is_corresponding":false,"raw_author_name":"Jan Stasko","raw_affiliation_strings":["Department of Haematology and Transfusion Medicine, National Centre of Haemostasis and Thrombosis, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Kollarova 2, 036 59 Martin, Slovakia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology and Transfusion Medicine, National Centre of Haemostasis and Thrombosis, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Kollarova 2, 036 59 Martin, Slovakia;","institution_ids":["https://openalex.org/I74788687"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5013258073"],"corresponding_institution_ids":["https://openalex.org/I74788687"],"apc_list":null,"apc_paid":null,"fwci":0.7548,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.72099703,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"52","issue":"4","first_page":"227","last_page":"231"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.6089000105857849,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.6089000105857849,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.19419999420642853,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.15119999647140503,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dabigatran","display_name":"dabigatran","score":1.0},{"id":"https://openalex.org/keywords/direct-thrombin-inhibitors","display_name":"direct thrombin inhibitors","score":0.7850000262260437},{"id":"https://openalex.org/keywords/platelet-aggregation","display_name":"platelet aggregation","score":0.8849999904632568},{"id":"https://openalex.org/keywords/thrombin","display_name":"thrombin","score":0.875},{"id":"https://openalex.org/keywords/atrial-fibrillation","display_name":"atrial fibrillation","score":0.9419999718666077},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.9020000100135803},{"id":"https://openalex.org/keywords/anticoagulation","display_name":"anticoagulation","score":0.722000002861023},{"id":"https://openalex.org/keywords/long-term-drug-therapy","display_name":"long-term drug therapy","score":0.6380000114440918}],"concepts":[{"id":"https://openalex.org/C2778810321","wikidata":"https://www.wikidata.org/wiki/Q419345","display_name":"Dabigatran","level":4,"score":0.9794949293136597},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9480386972427368},{"id":"https://openalex.org/C2777292125","wikidata":"https://www.wikidata.org/wiki/Q409166","display_name":"Thrombin","level":3,"score":0.6018630266189575},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.5875585675239563},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.5803032517433167},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5719559788703918},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5154450535774231},{"id":"https://openalex.org/C2776710957","wikidata":"https://www.wikidata.org/wiki/Q5280395","display_name":"Direct thrombin inhibitor","level":5,"score":0.42184627056121826},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3901853561401367},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3543564975261688},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.25283002853393555}],"mesh":[{"descriptor_ui":"D000069604","descriptor_name":"Dabigatran","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000069604","descriptor_name":"Dabigatran","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000991","descriptor_name":"Antithrombins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000991","descriptor_name":"Antithrombins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001792","descriptor_name":"Blood Platelets","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001792","descriptor_name":"Blood Platelets","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010974","descriptor_name":"Platelet Aggregation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D010979","descriptor_name":"Platelet Function Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013917","descriptor_name":"Thrombin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016022","descriptor_name":"Case-Control Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/14017431.2018.1480798","doi":"https://doi.org/10.1080/14017431.2018.1480798","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14017431.2018.1480798","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14017431.2018.1480798?needAccess=true&role=button","source":{"id":"https://openalex.org/S1492939","display_name":"Scandinavian Cardiovascular Journal","issn_l":"1401-7431","issn":["1401-7431","1651-2006"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scandinavian Cardiovascular Journal","raw_type":"journal-article"},{"id":"pmid:29842807","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29842807","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scandinavian cardiovascular journal : SCJ","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/14017431.2018.1480798","doi":"https://doi.org/10.1080/14017431.2018.1480798","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14017431.2018.1480798","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14017431.2018.1480798?needAccess=true&role=button","source":{"id":"https://openalex.org/S1492939","display_name":"Scandinavian Cardiovascular Journal","issn_l":"1401-7431","issn":["1401-7431","1651-2006"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scandinavian Cardiovascular Journal","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G2638044634","display_name":"Genetick\u00e9 pozadie a monitoring zmien hemost\u00e1zy v mana\u017emente von Willebrandovej choroby","funder_award_id":"1/0187/17","funder_id":"https://openalex.org/F4320323641","funder_display_name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV"},{"id":"https://openalex.org/G4327169902","display_name":null,"funder_award_id":"VEGA 1/0187/17","funder_id":"https://openalex.org/F4320323641","funder_display_name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV"}],"funders":[{"id":"https://openalex.org/F4320323641","display_name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV","ror":"https://ror.org/044gwpv05"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2805217833.pdf","grobid_xml":"https://content.openalex.org/works/W2805217833.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W1493000949","https://openalex.org/W1568759852","https://openalex.org/W1854704635","https://openalex.org/W1983727955","https://openalex.org/W2011620007","https://openalex.org/W2012761317","https://openalex.org/W2091112630","https://openalex.org/W2095803174","https://openalex.org/W2103888323","https://openalex.org/W2113089341","https://openalex.org/W2136489990","https://openalex.org/W2151073767","https://openalex.org/W2284149813","https://openalex.org/W2291575320","https://openalex.org/W2482669389","https://openalex.org/W2620971690","https://openalex.org/W2762279204","https://openalex.org/W2765277184","https://openalex.org/W2777071219"],"related_works":["https://openalex.org/W2777071219","https://openalex.org/W2734745814","https://openalex.org/W2620971690","https://openalex.org/W2948036825","https://openalex.org/W2328860365","https://openalex.org/W2322379362","https://openalex.org/W1854704635","https://openalex.org/W2990031521","https://openalex.org/W4249057748","https://openalex.org/W2318573661"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Dabigatran":[1],"is":[2,12,15,182],"a":[3,175,191],"direct":[4],"thrombin":[5],"inhibitor.":[6],"As":[7],"the":[8,30,127],"main":[9],"adverse":[10],"event":[11],"bleeding,":[13],"it":[14,27],"relevant":[16],"whether":[17],"dabigatran":[18,56,90,105,136,172,189],"has":[19],"additional":[20],"effects":[21],"on":[22,135],"platelet":[23,71,97,131,161,180],"function.":[24],"If":[25],"so,":[26],"could":[28],"affect":[29],"bleeding":[31],"risk.":[32],"We":[33,49,67],"aimed":[34],"to":[35,109,142],"assess":[36],"in":[37,40,78,88,119,133,160,168,184],"vitro":[38],"aggregation":[39,72,98,132,162,181],"patients":[41,53,134,169,187],"with":[42,55,74],"atrial":[43],"fibrillation":[44],"(AF)":[45],"receiving":[46,188],"dabigatran.":[47],"DESIGN:":[48],"evaluated":[50],"32":[51],"AF":[52,186],"treated":[54],"(study":[57],"group)":[58],"and":[59],"18":[60],"non-anticoagulated":[61],"non-AF":[62],"blood":[63],"donors":[64],"(control":[65],"group).":[66],"assessed":[68],"light":[69],"transmittance":[70],"(LTA)":[73],"100":[75],"nmol/L":[76],"\u03b3-thrombin":[77],"both":[79],"groups.":[80],"The":[81,95,178],"LTA":[82],"was":[83,99,106,138,165],"performed":[84],"at":[85,163],"two":[86,102],"time-points":[87],"our":[89,120],"group":[91],"of":[92,130],"patients.":[93],"RESULTS:":[94],"thrombin-induced":[96,179],"significantly":[100,139],"lower":[101,140],"hours":[103],"after":[104,190],"taken":[107],"compared":[108,141],"baseline":[110,128,164],"measurement":[111],"(9%":[112],"\u00b1":[113,117,146,150],"6%":[114],"vs.":[115,148],"29%":[116],"21%)":[118],"study":[121],"group.":[122],"Moreover,":[123],"we":[124],"observed":[125,167],"that":[126,156],"value":[129],"treatment":[137],"healthy":[143],"volunteers":[144],"(29%":[145],"21%":[147],"89":[149],"8).":[151],"However,":[152],"one":[153],"subanalysis":[154],"showed":[155],"this":[157],"significant":[158],"reduction":[159],"only":[166],"who":[170],"received":[171],"for":[173],"over":[174],"week.":[176],"CONCLUSION:":[177],"reduced":[183],"non-valvular":[185],"week-long":[192],"therapy.":[193]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":4}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2018-06-13T00:00:00"}